Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 4.12
Ask: 4.70
Change: 0.94 (27.09%)
Spread: 0.58 (14.078%)
Open: 3.64
High: 4.80
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New PREtec Products Announced

28 Sep 2023 07:00

RNS Number : 8895N
Plant Health Care PLC
28 September 2023
 

28 September 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

New PREtec Products Announced

 

Brazilian Launch of MOSHY™ and TEIKKO™ planned

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce two new brands - MOSHY and TEIKKO - derived from the Company's PREtec technology platform (Vaccines for PlantsTM) for launch in Brazil for the 2024 soybean growing season.

 

Highlights:

 

· MOSHY (PHC25279) is a foliar product registered in Brazil to control foliar diseases in coffee and sugar cane.

· TEIKKO (PHC68949) is a seed treatment to control harmful soil nematodes in soybean fields. This is expected to be registered in Brazil before the end of 2023.

· MOSHY and TEIKKO add to the portfolio of Plant Health Care products available to growers in Brazil.

· Discussions with potential Brazilian distributors of MOSHY and TEIKKO are ongoing.

· For the six months ended 30 June 2023, revenue in Brazil was up 48%, driven by in-market demand for H2Copla® (Harpinαβ) and Saori® (PREtec).

 

MOSHY and TEIKKO provide specific benefits for growers of improved disease and nematode control, plant health and yield.

 

MOSHY helps control a broad spectrum of plant diseases when used as part of an integrated disease control program. MOSHY was shown to reduce the incidence and severity of sugar cane orange rust and coffee leaf rust leading to significant increases in yield. Brazil is the world's largest producer of sugar cane and coffee. As part of Plant Health Care's continued investment in Brazilian agriculture, additional crop specific, plant pathogen claims will be added to the MOSHY product label, allowing use on a wider range of crops.

 

TEIKKO is a novel product that amplifies a plant's natural defense pathways to provide protection against plant parasitic nematodes which damage plant roots and limit crop yield. TEIKKO was submitted as a seed treatment for the control of root-lesion nematode (Pratylenchus brachyurus) in soybean. Research carried out during the 2021/22 and 2022/23 soybean crop seasons showed that TEIKKO controlled Pratylenchus brachyurus in soybeans, with similar or superior performance when compared to standard market treatments. For the 2023/24 season, the soybean harvested area in Brazil is forecast to be 45.6 million hectares. Additional crops and nematode species will be added to the TEIKKO product label further expanding its potential use.

 

Both products are based on the Company's innovative PREtec technology platform. Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates plant defense and pathogen resistance mechanisms within plants, resulting in improved crop growth and quality along with the ability to withstand a variety of abiotic stresses. 

 

As well as launching new products in its existing markets, Plant Health Care continues to expand into new markets around the world and is growing its relationships with major global distribution partners. As a result, the Company is on track to achieve revenue of $30 million by 2025.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Plant Health Care continues to scale our global business with the addition of TEIKKO and MOSHY to the Brazil product line which includes H2Copla and Saori. Plant Health Care's biological products have earned the reputation of contributing to sustainable agriculture while increasing yields, controlling diseases, and generating a positive ROI for growers. We expect MOSHY and TEIKKO to be novel biological products that will deliver control of nematodes and diseases in critical Brazil crops. These new product launches are key steps for Plant Health Care in meeting our $30 million revenue target by 2025."

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

+1 919 926 1600

Cavendish Securities plc - Nomad & Broker Neil McDonald / Pete Lynch

+44 (0) 131 220 9771

SEC Newgate - Financial Communications Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PRLBUGDCISDDGXR
Date   Source Headline
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
23rd Aug 20167:00 amRNSBlock listing Interim Review
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.